Q: Who is this product suitable for
Metabolic regulation Activates AMPK, the cells master metabolic switch
The combined effect can increase the likelihood of breakouts
Mounjaro (Tirzepatide) Injection 12.5 mg/0.5 mL Prefilled Syringes are prescription medications used to treat type 2 diabetes. They contain 12.5 mg of tirzepatide, which is a glucagon-like peptide-1 (GLP-1) receptor agonist and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist
Best fit First GLP-1 program, Food noise, Weekly appetite control Compounded Semaglutide should be evaluated by goal fit, safety fit, evidence strength, and provider oversight
Healthcare professionals should approach disclosures of combined peptide use with a non-judgemental but clinically thorough assessment, and provide harm-minimisation advice where appropriate